CANNAPHARMARX, INC.

CPMD ·Healthcare, Drug Manufacturers - General
Financial Statements SEC Filings

SEC Filings

Form Filed Description
10-Q/A Nov 20, 2019 FORM 10-Q AMENDMENT NO. 1
10-Q/A Nov 20, 2019 FORM 10-Q AMENDMENT NO. 1
10-Q Nov 14, 2019 FORM 10-Q
8-K Oct 3, 2019 FORM 8-K
10-K/A Aug 14, 2019 FORM10-K AMENDMENT
10-Q Aug 14, 2019 FORM 10-Q
3 Jun 26, 2019 PRIMARY DOCUMENT
3 Jun 26, 2019 PRIMARY DOCUMENT
8-K Jun 12, 2019 FORM 8-K
10-Q May 15, 2019 FORM 10-Q
DEF 14A Apr 30, 2019 DEF 14A
8-K Apr 26, 2019 CURRENT REPORT
4 Apr 18, 2019 PRIMARY DOCUMENT
4 Apr 17, 2019 PRIMARY DOCUMENT
4/A Apr 16, 2019 PRIMARY DOCUMENT
10-K Apr 3, 2019 FORM 10-K
NT 10-K Apr 1, 2019 NOTICE OF LATE FILING
D Mar 13, 2019
3 Mar 12, 2019 PRIMARY DOCUMENT
8-K Mar 1, 2019 FORM 8-K
8-K/A Feb 14, 2019 FORM 8-K AMENDMENT
8-K Jan 30, 2019 FORM 8-K
D/A Jan 18, 2019
8-K/A Jan 7, 2019 FORM 8-K AMENDMENT
DEF 14C Dec 18, 2018 DEFINITIVE INFORMATION STATEMENT
← Newer Page 6 of 14 · 338 filings Older →